Arphra
live
S&P 5000.34
NASDAQ0.00
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1576+0.37%
GOLD4,242.2+4.38%
WTI85.83-7.70%
BTC63,338+3.09%
S&P 5000.34
NASDAQ0.00
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1576+0.37%
GOLD4,242.2+4.38%
WTI85.83-7.70%
BTC63,338+3.09%

TN8.DE

Thermo Fisher Scientific Inc.
HealthcareMedical - Diagnostics & ResearchUSEURPeers →
$411.30
Jun 11, 2026
AI Brief
Market cap
$176.77B
52w range
P / E
EPS
Volume
Revenue · FY

Explain this page

Arphra AI
Business description
· company · SEC profile

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global provider of diverse scientific solutions, offering life sciences tools, advanced analytical instruments, specialized diagnostic products, laboratory supplies, and biopharmaceutical services across the United States and internationally. Its Life Sciences Solutions division delivers essential reagents, sophisticated instruments, and consumables vital for biological and medical research, the discovery and production of drugs and vaccines, and the identification of infections and diseases. This segment encompasses biosciences, genetic sciences, advanced clinical sequencing, and bioproduction, serving a wide array of markets such as pharmaceutical, biotechnology, agriculture, clinical, healthcare, academic, and governmental institutions. The Analytical Instruments segment furnishes instrumentation, accompanying consumables, software, and support services utilized in laboratory settings, on production lines, and in field applications. These offerings cater to pharmaceutical, biotechnology, academic, governmental, environmental, and other industrial research markets, as well as clinical laboratories. Through its Specialty Diagnostics segment, the company supplies a comprehensive range of diagnostic resources. This includes liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, along with calibrators, controls, and calibration verification fluids. This unit is particularly noted for engineering, manufacturing, and marketing complete blood test systems designed for the clinical diagnosis and ongoing monitoring of allergies, asthma, and autoimmune diseases. Additionally, it provides culture media, collection and transport systems, instruments, consumables, and crucial human leukocyte antigen (HLA) typing and testing services for organ transplantation, among other healthcare-related items. The Laboratory Products and Biopharma Services segment supports scientific undertakings by supplying various laboratory products and chemicals, facilitating access to research and safety markets, and delivering pharmaceutical services and clinical research assistance. Thermo Fisher Scientific connects with its customers via a robust network that includes a direct sales team, dedicated customer service specialists, online commerce platforms, authorized third-party distributors, and product catalogs. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

Founded
IPO
Feb 18, 2020
Employees
125,000
HQ
Waltham, MA
CEO
Marc N. Casper
CFO
Exchange
XETRA
Fiscal year
Identifiers
· company_identifiers
CIK
CUSIP883556102
ISINUS8835561023
FIGITN8 GY
LEI
Cross-listings
· companies · ISIN
  • TMOPrimaryNew York Stock ExchangeusUSD$183.61B
  • TN8.DEDeutsche Börse XETRAusEUR$180.12B
  • 0R0H.LLondon Stock ExchangeusUSD$1.82B
  • TMO.NENEOCAD
The global universe keeps only the primary listing; the other venues for this security are shown here.